Brief: Cereno Announces New Patent Issued In 25 European Countries
March 22 (Reuters) - Cereno Scientific AB CRNOSb.ST :
* ANNOUNCES NEW PATENT ISSUED IN 25 EUROPEAN COUNTRIES FOR
PHASE
II DRUG CANDIDATE CS1
* PATENT WILL BE VALID THROUGH 2037 WITH POSSIBILITY OF
PATENT
EXTENSION OF UP TO FIVE YEARS
Source text for Eikon: ID:nWkr8N8N08
Further company coverage: CRNOSb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Carries Out Directed Share Issue Of SEK 60 Mln
Brief: Cereno Scientific Strengthens Patent Protection For Cs1 In Canada
Sweden's Cereno Scientific Q1 net loss widens amid clinical development
Brief: Cereno Scientific Q1 Loss After Financial Items SEK 28.6 Mln
Brief: Cereno Enters Collaboration With PHA Europe & Global